Markets:

Overview

News

Currencies

International

Treasuries

Gilead Sciences (NQ:GILD)

120.98 +2.68 (+2.27%)

Streaming Delayed Price Updated: 9:54 AM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Gilead Sciences

< Previous 1 2 3 4 5 6 7 8 9

...

69 70 Next >

Gilead Sciences Inc (NASDAQ:GILD) Shows Strong Technical Setup for Potential Breakout ↗

September 24, 2025

Gilead Sciences (GILD) shows strong technicals with a top rating of 9. It's forming a high-quality consolidation pattern, suggesting a potential breakout above $117.42.

Via Chartmill

If You Invested $100 In Gilead Sciences Stock 20 Years Ago, You Would Have This Much Today ↗

September 23, 2025

Via Benzinga

3 Profitable Stocks We’re Skeptical Of

September 23, 2025

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

Via StockStory

Cumberland First in Families to Host 2nd Annual Mister & Miss FIFNC Pageant

September 18, 2025

Via Get News

What Analysts Are Saying About Gilead Sciences Stock ↗

September 16, 2025

Via Benzinga

SLB, Apple, Nvidia, Merck, Gilead Sciences: What Sparked Heavy After-Hours Trading In These 5 Stocks? ↗

September 11, 2025

Via Stocktwits

Why Is Novo Nordisk’s Stock Rising Premarket Today? ↗

September 10, 2025

Via Stocktwits

Xilio Stock Jumps 8% On Cancer Drug Data; Gilead Boost Extends Cash Runway Into 2027 — Retail Says Stock Undervalued ↗

September 09, 2025

Via Stocktwits

3 Reasons GILD is Risky and 1 Stock to Buy Instead

September 16, 2025

Gilead Sciences has been treading water for the past six months, holding steady at $112.78. The stock also fell short of the S&P 500’s 16.5% gain during that period.

Via StockStory

Topics Government Stocks

U.S. Economy Braces for Significant Slowdown: Leading Indicators Signal Weakening, Not Yet Recession

September 15, 2025

The U.S. economy finds itself at a critical juncture, as signals from The Conference Board's Leading Economic Index (LEI) point toward a sustained period of economic weakening. While the LEI's...

Via MarketMinute

Topics Artificial Intelligence Economy Supply Chain

These S&P500 stocks are gapping in today's session ↗

September 15, 2025

Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Monday. Stay informed about the latest market trends.

Via Chartmill

Biotech Sector May Flip to Market Leader by Year-End ↗

September 15, 2025

As rate cuts loom and after years of lagging, the biotech sector is showing signs of life, with IBB outpacing the benchmark S&P 500 on the quarter.

Via MarketBeat

Topics ETFs Economy Stocks

GILEAD SCIENCES INC (NASDAQ:GILD): A Prime Value Investing Candidate with Strong Fundamentals ↗

September 13, 2025

Gilead Sciences (GILD) is a strong value investing candidate, trading at a significant discount with high profitability, solid financial health, and positive growth prospects.

Via Chartmill

Tariffs Cast a Long Shadow: Consumer Prices Soar Across Essential Goods

September 10, 2025

American households are bracing for a significant financial hit as a wave of tariff-induced inflation sweeps across critical consumer goods and services. From the family car to essential baby products,...

Via MarketMinute

Topics Economy Government World Trade

Cooling Wages Cast a Shadow: Economic Recovery at Risk as Consumer Spending Slows

September 10, 2025

The American economy is facing a new headwind as weakening wage growth begins to temper consumer spending, raising concerns about the pace and sustainability of the broader economic recovery. Recent...

Via MarketMinute

Topics Credit Cards Economy Supply Chain

InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) to Present at LSX World Congress 2025

September 10, 2025

Via Investor Brand Network

Topics Intellectual Property

Wolfspeed, Nvidia, Gilead, SLBM, Corning: What Sparked Heavy After-Hours Trading In These 5 Stocks? ↗

September 09, 2025

On Monday, the tech-heavy Nasdaq Composite climbed to a new high despite the ongoing uncertainty regarding the state of the U.S. economy and the rate outlook.

Via Stocktwits

Topics Artificial Intelligence Bankruptcy Economy

Global Economic Slowdown and Escalating Tariffs: A Looming Threat to Market Growth

September 08, 2025

The global economy is currently grappling with a projected deceleration in GDP growth, a situation severely exacerbated by an unprecedented escalation of U.S. tariffs. These twin forces are creating a...

Via MarketMinute

Topics Economy Supply Chain World Trade

2024 R&D Spending and Intensity Benchmarks

September 08, 2025

Via PRLog

Topics Supply Chain

Gilead Announces Partnership With PEPFAR to Deliver Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries

September 04, 2025

From Gilead Sciences, Inc.

Via Business Wire

Gilead Sciences Launches Choose U™ Campaign Spotlighting the Inspiring Experiences of People Living with HIV

September 04, 2025

From Gilead Sciences, Inc.

Via Business Wire

Gilead Sciences Breaks Ground on New Manufacturing Hub, a Cornerstone of Its U.S. Growth and Innovation Strategy

September 03, 2025

From Gilead Sciences, Inc.

Via Business Wire

1 Healthcare Stock to Consider Right Now and 2 We Question

September 03, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged recently as players offloaded surplus COVID...

Via StockStory

Topics Stocks

Beating The September Curse–These 10 Stocks Shine While The S&P 500 Stumbles ↗

September 02, 2025

September is historically the worst month for stocks, but these 10 S&P 500 companies have consistently delivered gains.

Via Benzinga

Topics Stocks

Veeva Makes A Bearish Move On One Pockmark In Its Quarterly Report ↗

August 27, 2025

The company beat second-quarter expectations, with the exception of one key metric.

Via Investor's Business Daily

Eli Lilly Scores Another Weight-Loss Win; Viking, Novo Stocks Slump ↗

August 26, 2025

Eli Lilly said Tuesday it will soon ask global regulators to approve its weight-loss pill following a third successful test.

Via Investor's Business Daily

Gilead Sciences' 99.9% Effective HIV Treatment Notches Another Win ↗

August 26, 2025

The drug is soon to launch in Europe with a new name and a big potential market.

Via Investor's Business Daily

European Commission Authorizes Twice-Yearly Yeytuo® (Lenacapavir) for HIV Prevention

August 26, 2025

From Gilead Sciences, Inc.

Via Business Wire

Options Corner: Why The Market Could Be Prescribing A Bull Call Spread For Gilead Sciences ↗

August 25, 2025

While Gilead Sciences posted a strong Q2 earnings print, GILD stock saw profit-taking. Here's why the red ink could be an opportunity.

Via Benzinga

Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years ↗

August 22, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

69 70 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.